Home Cart Sign in  
Chemical Structure| 101827-46-7 Chemical Structure| 101827-46-7

Structure of Butenafine HCl
CAS No.: 101827-46-7

Chemical Structure| 101827-46-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Butenafine HCl is a synthetic benzylamine antifungal targeting on squalene epoxidase working by inhibiting the synthesis of ergosterol needed in fungal cell membranes.

Synonyms: KP363 Hydrochloride; Butenafine (hydrochloride); KP-363

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Butenafine HCl

CAS No. :101827-46-7
Formula : C23H28ClN
M.W : 353.93
SMILES Code : CN(CC1=CC=C(C(C)(C)C)C=C1)CC2=C3C=CC=CC3=CC=C2.[H]Cl
Synonyms :
KP363 Hydrochloride; Butenafine (hydrochloride); KP-363
MDL No. :MFCD00917064
InChI Key :LJBSAUIFGPSHCN-UHFFFAOYSA-N
Pubchem ID :443867

Safety of Butenafine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Trichophyton rubrum >128 µg/ml 7 days Evaluate the antifungal activity of Butenafine against Trichophyton rubrum, showing complete cross-resistance to Butenafine Antimicrob Agents Chemother. 2003 Jan;47(1):82-6
Candida albicans KC-36 12.5 μg/ml 10 min Induced the release of intracellular Pi Antimicrob Agents Chemother. 1993 Apr;37(4):785-8
Candida albicans KC-36 0.057 μg/ml 2 h Inhibited squalene epoxidation, with 50% inhibitory concentration of 0.057 μg/ml Antimicrob Agents Chemother. 1993 Apr;37(4):785-8
Candida albicans KC-36 50 μg/ml Cidal effect on C. albicans Antimicrob Agents Chemother. 1993 Apr;37(4):785-8
Candida albicans KC-36 25 μg/ml Completely inhibited the growth of C. albicans Antimicrob Agents Chemother. 1993 Apr;37(4):785-8

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01119742 Interdigital Tinea Pedis Phase 1 Terminated(Insufficient number... More >> of baseline eligible patient) Less << - -
NCT00835510 Tinea Pedis Phase 1 Completed - United States, California ... More >> Investigator Site Burbank, California, United States Investigator Site San Diego, California, United States United States, Florida Investigator Site Miami, Florida, United States United States, Georgia Investigator Site Martinez, Georgia, United States Investigator Site Stockbridge, Georgia, United States United States, Michigan Investigator Site Clinton Township, Michigan, United States United States, North Carolina Investigator Site Hickory, North Carolina, United States Investigator Site Raleigh, North Carolina, United States Investigator Site Salisbury, North Carolina, United States United States, Ohio Investigator Site Sylvania, Ohio, United States United States, South Carolina Investigator Site Simpsonville, South Carolina, United States United States, Tennessee Investigator Site Bristol, Tennessee, United States Investigator Site Nashville, Tennessee, United States United States, Texas Investigator Site College Station, Texas, United States Investigator Site Houston, Texas, United States Investigator Site San Antonio, Texas, United States Belize Investigator Site Belize City, Belize Less <<
NCT01580878 Tinea Pedis Phase 1 Completed - -
NCT00835510 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.83mL

0.57mL

0.28mL

14.13mL

2.83mL

1.41mL

28.25mL

5.65mL

2.83mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories